Funding @ 2018-12-11 11:38:55 UTC 737d93b80e91a2757cfbace749619cd7aa175ed66beec44ac272b541c40ce13c:0
Spending @ 2018-12-11 12:25:32 UTC 35d094254782505292e14b324ad9115c7b889eeb69c7466a08678c807e89a8c3:0
|
Funding @ 2018-12-05 15:26:09 UTC 72032162172264a410ab58578db39813f386782789ad68217776bcc0c8281c21:0
Spending @ 2018-12-05 15:35:37 UTC d2b9524d323d5cebe5097bafbf5781ff3c5d754270bc2eb6482a03ce41c2abbc:37
|
Funding @ 2018-11-25 01:58:44 UTC 7c6c03e22a2fa1626c765d6288aee59a7a5bd481c4fc7a8313e5dd13b81ceaf8:2
Spending @ 2018-11-25 03:31:04 UTC cd2bfa7b4bf2290ca7c2977358fc7aa1be0993f5b89213be1f1698d34014a5e6:93
|
Funding @ 2018-11-24 15:52:42 UTC 566b1df4d8a3e52d0a6301866e8dc215cc859ce041d73a6466ee849ba778f034:0
Spending @ 2018-11-24 20:48:14 UTC 2fdafb0e83e0639a9d22fd2454b381f308c7e99af6825dff922a2eb00247e810:96
|
Funding @ 2018-11-17 09:13:01 UTC fdf5cc21b52c87c36769e106531ea6e50bda3baa0bb1edf5c48a2fedc313151d:0
Spending @ 2018-11-18 00:51:49 UTC 8f55b52e94ffab3e126d690d777f518010ac2f44cf94facddc2cfc15300b3eec:44
|
Funding @ 2018-11-17 06:10:07 UTC 33efc18ef5fe8d095f60eac85a7d8e42b7aa5a8cbb0a1935bf2d846c771c9221:19
Spending @ 2018-11-17 16:51:56 UTC f1c8d3c3bee6106273e0fc8983e4dcc05752bdc5decf6b339e6bdc4a60278c11:56
|
Funding @ 2018-11-01 15:26:17 UTC bd06b9acedafb48f08d56c48a6c938a2fbfd313c74cd8890d17ce66d323fbb58:0
Spending @ 2018-11-01 16:34:30 UTC e4e6f38051bf4b123d6fed8ab45c65ec1545cbbcbe60587565a1360fc4d6253b:61
|
Funding @ 2018-11-01 13:34:27 UTC e273c476b6fe5214bf3a237417cb36b302706377d464c357548303a281c9bb18:0
Spending @ 2018-11-01 14:22:08 UTC 7d2222f2bead60237da62d3f928c74b489010906b388825e3ba4285932193463:3
|
Funding @ 2018-10-30 08:48:38 UTC 8c6ed241f77b6d96186dac846b8a14ae2addcf86162efece31c9572ff2521f94:0
Spending @ 2018-10-30 09:44:20 UTC fafd72c9483eee972ad1fa7ac95177e0fbf237bb64e9c4db72d7a37f8dfecf66:30
|
Funding @ 2018-10-30 08:03:13 UTC 6c99eb1ae5a2181a64cb8dba71a59cd20cbcc2012a202aebf0120a8de50586d8:0
Spending @ 2018-10-30 08:14:40 UTC 859c0fb8d6d299eff625fb4655c873373791ca83b5255c9839f361bf950e2fda:100
|
